Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Lilly Declares Fourth-Quarter 2014 Dividend
Janssen Pharmaceuticals and Diabetes Hands Foundation Encourage People with Type 2 Diabetes to Get Moving for National Diabetes Month
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis
OFEV® (nintedanib) Now Available in the United States
USA MedicalCard Plans More Extensive Outreach With The Upcoming National Mailing Of Its Free Pharmacy Discount Card
Drug Delivery Technologies Market Forecast 2014-2024
Cypher Genomics Identifies and Verifies Genetic Cause of Rare Disease, Epileptic Encephalopathy
The Age-Related Macular Degeneration Drug Market Will Grow to Nearly $9 Billion in 2023, Fueled in Part by the Anticipated Launch of the First Therapies for Geographic Atrophy
Global Alliance for Genomics and Health Members Meet to Advance Genomic Data Sharing
Milo Biotechnology's Follistatin Gene Therapy Increases Function in Becker Muscular Dystrophy Patients
Pinney Associates, Inc. Celebrates 20th Anniversary
New Large-Scale Study Will Look at How Nutrition Can Help Keep Patients from Returning to the Hospital
RegeneRx Allowed to Proceed with Phase 3 Using RGN-259 Eye Drops for the Treatment of Neurotrophic Keratopathy
The Zacks Analyst Blog Highlights: GlaxoSmithKline, NewLink Genetics, Allergan, Inovio Pharmaceuticals and BioCryst Pharmaceuticals
Global and Chinese Cysteine Methyl Ester Industry Report 2014
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma
LabStyle Innovations to Demonstrate the Dario Smart Meter at the Upcoming Annual Canada Diabetes Association Conference
Sascha Becker Will Join Grünenthal Group as new CFO
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt
Eisai Announces FDA Acceptance of Supplemental New Drug Application for Antiepileptic Drug Perampanel as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant
Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production
IMBRUVICA® (ibrutinib) Supplemental New Drug Application Submitted to the U.S. FDA for Waldenstrom's macroglobulinemia
The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth
Pharmaceutic Labs Opens CGMP Outsourcing Facility in Albany, NY
Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy
Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs
Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets
IGI Laboratories To Hold Conference Call For 3rd Quarter 2014 Results
Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults
AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement
Zola P. Horovitz To Retire From GenVec Board
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis
TesoRx and Aspen Group Conclude Investment and Licensing Agreement
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in Cancer, the Peer-Reviewed Journal of the American Cancer Society
Survey Shows 90% of Adults Unaware of Men's Risk for Osteoporosis
Interim Chief Financial Officer James Bowling to Step Down
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014
HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug
Autism and Endometriosis Therapeutic Pipeline (Company and Drugs Profiles) Review H2 2014
Effective Training Programs for Market Research Groups can Boost Overall Organizational Success
Early Key Findings from the Medical Affairs Consortium Research
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors
Talyst Exhibits at LeadingAge Annual Meeting
Growth of Wound Care Market (Products) Steady Across the World, Say New Research Reports
Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments
Solid Organ Transplant Immunosuppressant Middle East & Africa Market Analysis Report

< Prev Next >
PR Newswire - United Business Media